4th Quarter - Report

GLOBAL BLOOD THERAPEUTICS for GLOBAL BLOOD THERAPEUTICS

Firm
Client
Income
—
Expenses
$170,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

One issue area, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

SCD funding; Drug pricing (HR 3); access to SCD treatment and care

LobbyistCovered position, as disclosed
AARON KRUPP —

Contacted: Health & Human Services, Dept of (HHS); SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 3 (116th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.